Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Penumbra Inc (NY: PEN )

131.75 +4.17 (+3.27%)
Official Closing Price Updated: 4:10 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 335,024
Open 129.17
Bid (Size) 121.58 (1)
Ask (Size) 257.26 (1)
Prev. Close 127.58
Today's Range 128.03 - 132.38
52wk Range 114.86 - 293.19
Shares Outstanding 36,580,540
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Penumbra's Return on Invested Capital Insights
Pulled from Benzinga Pro data, Penumbra (NYSE:PEN) posted Q1 earnings of $79.00 thousand, an increase from Q4 of 100.32%. Sales dropped to $203.90 million, a 0.06% decrease between quarters. 
Via Benzinga
Despite Seeing Accelerated 2023 Growth, This Analyst Cut Penumbra's Price Target - Here's Why
 
Via Benzinga

Performance

YTD
-53.61%
-53.61%
1 Month
-5.93%
-5.93%
3 Month
-35.94%
-35.94%
6 Month
-52.19%
-52.19%
1 Year
-52.93%
-52.93%

More News

Read More
What 4 Analyst Ratings Have To Say About Penumbra
Via Benzinga
Penumbra: Q1 Earnings Insights
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Penumbra Announces the European Launch of the Indigo® System With Lightning™ 7 and Lightning 12 Intelligent Aspiration
From Penumbra, Inc.
Via Business Wire
Recap: Penumbra Q4 Earnings
Via Benzinga
Earnings Scheduled For May 3, 2022
Via Benzinga
Earnings Scheduled For February 22, 2022
Via Benzinga
Earnings Outlook For Penumbra
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2022
Via Benzinga
28 Biggest Movers From Yesterday
Via Benzinga
Penumbra Introduces Next Generation REAL® y-Series™, Expanding Virtual Reality Healthcare Platform
From Penumbra, Inc
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
Via Benzinga
Penumbra Posts Mixed Bag Q4 Results, Reports Topline Growth Of 22%
Via Benzinga
Penumbra's Return on Invested Capital Insights
Via Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Via Benzinga
Penumbra Weighs Combination With Shockwave Medical: Bloomberg
Via Benzinga
CEO Of Penumbra Trades $3.9M In Company Stock
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Penumbra's Thrombectomy System Shows Safety, Clinical Benefit
Via Benzinga
New Data Demonstrates Safety and Performance of Continuous Aspiration Thrombectomy with Penumbra’s Indigo® System CAT™ RX Catheter in High-Risk Patients with Acute Coronary Syndrome
From Penumbra, Inc.
Via Business Wire
Penumbra, Inc (PEN) Q3 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
Via Benzinga
Topics Retirement
Exposures Pension
Earnings Scheduled For November 3, 2021
Via Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.